Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study

Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Update From an Unicentric, Regional Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04839913

Acronym

COVID-19

Enrollment

121

Registered

2021-04-09

Start date

2020-09-01

Completion date

2021-01-10

Last updated

2021-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, SARS-CoV Infection, Seroprevalence

Brief summary

The investigator analyzed the data of the patients admitted to the surgical department during the period 1St September - 10Th December 2020 to estimate the seroprevalence of SARS-CoV-2 infection in the setting of a non-dedicated COVID-19 hospital and in a mild CoV-2 incidence area and to evaluate the difference of seroprevalence between Spring and Fall seasons in a cohort of patients undergoing surgery.

Interventions

DIAGNOSTIC_TESTAntibodies testing

Serologic test for both SARS-COV-2 IgG and IgM

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient admitted to our unit who had performed SARS-COV-2 serologic test

Exclusion criteria

* age \< 18

Design outcomes

Primary

Measure	Time frame	Description
SARS-COV-2 seroprevalence	1St September - 10Th December 2020	SARS-COV-2 IgG and IgM seroprevalence between spring and fall period

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026